Role of microRNA-451a in molecular pathology of cancer
Cancer Treatment and Research Communications · 2026
DOI: 10.1016/j.ctarc.2026.101295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Meysam Moghbeli. Beteiligte Einrichtung: Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
MicroRNAs (miRNAs) are short non-coding RNAs that modulate gene expression at the post-transcriptional level and have been recognized as the critical players in tumor initiation and metastasis. Their aberrant expression patterns offer substantial clinical utility as diagnostic and prognostic biomarkers and represent promising therapeutic targets. Among these, miR-451a, encoded on chromosome 17q11.2 in a region frequently deleted in malignancies, has attracted considerable attention. MiR-451a is predominantly downregulated and acts as a potent tumor suppressor in a wide spectrum of cancers. Mechanistically, it directly targets key oncogenes, thereby inhibiting cell proliferation and invasion while promoting apoptosis and enhancing sensitivity to chemo- and radiotherapy. Clinically, low tumoral or circulating levels of miR-451a were correlated with advanced stage, poor differentiation, and unfavorable prognosis, underscoring its potential as a minimally invasive diagnostic and prognostic biomarker. Moreover, restoring miR-451a function via mimics or delivery systems is being actively investigated to overcome drug resistance and suppress metastatic dissemination, highlighting its translational promise. This review provides a comprehensive assessment of the molecular mechanisms and emerging clinical applications of miR-451a in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir.
Zitieren
APA
Moghbeli, M. (2026). Role of microRNA-451a in molecular pathology of cancer. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101295
Vancouver
Moghbeli M. Role of microRNA-451a in molecular pathology of cancer. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101295
BibTeX
@article{Moghbeli2026,
author = {Moghbeli, Meysam},
title = {Role of microRNA-451a in molecular pathology of cancer},
journal = {Cancer Treatment and Research Communications},
year = {2026},
doi = {10.1016/j.ctarc.2026.101295}
}
EUVIMED